Mix and match: New 3-D cell culture model replicates fibrotic elements of pancreatic cancer 07/22/2020 Health News, Pancreatic cancer is a life-threatening disease with very poor survival rates in patients, and—despite various...
Unexpected associations found between drug response and cell changes in brain cancer 07/14/2020 Health News, Therapies for treating glioblastoma brain cancer can be delivered with greater precision and existing drugs...
Critical window for re-infection with HIV after stem cell transplantation 05/14/2020 Health News, Some people with HIV need to undergo an allogeneic stem cell transplantation in order to...
Researchers find new insights linking cell division to cancer 04/29/2020 Health News, To replace aging and worn cells, the body primarily uses a process called mitosis, in...
Timing of brain cell death uncovers a new target for Alzheimer’s treatment 02/13/2020 Health News, Alzheimer's remains the leading cause of dementia in Western societies, with some estimates suggesting that...
Scientists discover immune cell subtype in mice that drives allergic reactions 08/02/2019 Health News, Allergies can be life-threatening when they cause anaphylaxis, an extreme reaction with constriction of the...
Combo Regimens Effective for Tx of Metastatic Renal Cell Cancer 02/20/2019 Health News, WEDNESDAY, Feb. 20, 2019 -- For first-line therapy of metastatic renal cell carcinoma, pembrolizumab plus...
Alzheimer’s: What leads to brain cell damage? 01/21/2019 Health News, The team at the Grenoble Institute of Neurosciences in France that made the discovery also...
New, rapid and robust method for single cell profiling 12/18/2018 Health News, Many of the cell types in our bodies work in obscure ways that science does...
G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer 10/23/2018 Medications, RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX),...